Insider · CIK 0002006649
Dale Curtis Hogue Jr.
Files at TCRT (Alaunos Therapeutics, Inc.). First filing -, latest -.
Dale Curtis Hogue Jr. files SEC Form 4 as officer and director at TCRT (Alaunos Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Dale Curtis Hogue Jr. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 29, 2025 | TCRT Alaunos Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Apr 1, 2025 |
Questions about Dale Curtis Hogue Jr.
Answered from the filings on this page, as of the latest one.
Is Dale Curtis Hogue Jr. buying or selling?
Dale Curtis Hogue Jr. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Dale Curtis Hogue Jr.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dale Curtis Hogue Jr. has 0.
Where does Dale Curtis Hogue Jr. file Form 4?
Dale Curtis Hogue Jr. has filed Form 4 at TCRT (Alaunos Therapeutics, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.